- Country: Spain
- Summary: Supply of Parenteral Cytostatic Medications with Active Ingredients Cabazitaxel, Arsenic Trioxide, Paclitaxel, Paclitaxel-Albumin, Bendamustina, Bortzomib, Busulfan, Carboplatin, Cisp ...
- EST Ref No: 119636913
- Deadline: 27 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 158400
- Notice Type: Tender
- Document Ref. No.: 333867-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of parenteral cytostatic medications with active ingredients Cabazitaxel, arsenic trioxide, paclitaxel, paclitaxel-albumina, Bendamustine, Bortzomib, Busulfan, Carboplatin, CISP ...
Supply of parenteral cytostatic medications with active principles Cabazitaxel, trioxide, trioxideof arsenic, paclitaxel, paclitaxel-albumina, Bendamustina, Bortzomib, Busulfan, Carboplatin, Cisplatin, Doxorubicin, Etoposido, Flebine, Gemcitabine, Iinotecan, Vinorelbin and Cyclophosphamide. Cabazitaxel, trioxideof arsenic, paclitaxel, paclitaxel-albumina, Bendamustina, Bortzomib, Busulfan, Carboplatin, Cisplatin, Doxorubicin, Etoposido, Flebin, Gemc.itabina, Irinotecan, Vinorelbin and Cyclophosfamide For the centers dependent on the Murcian Service of Health
Cabazite 60 mg via Intravenous
cisplatin100 mg
cisplatino 100 mg (1 mg/ml) via the doxorubicina 50 mg
doxorubicina 50 mg (2 mg/ml) via
etoposido 200 mg (20 mg/ml) via
etoposido 100 mg (20 mg/ml) via
Fludarabina 50 mg
Fludarabina Mg/ml) vial
gemcitabina 1000 mg vial concentrado para dilucion
gemcitabina 2000 mg vial ConcentradoPara Dilucion
Irinotecan 500 Mg (20 Mg/Ml) Vial
Vinorelbina 50 Mg (10 Mg/Ml) Vial
Ciclofosfamida Parenteral
Arsenico Trioxido Parenteral
Paclitaxel 300 Mg Vial
Paclitaxel 100 Mg
Paclitaxel 100 Mg (5 Mg/Ml) Via Intravenosa
Bendamustina 100 Mg Vial
Bendamustina 100 Mg Vial (2,5mg/Ml Y/O 25Mg/Ml)
Bortezomib 3,5 Mg Vial
Bortezomib 3,5 Mg Vial (Polvo Y/O Diluidos 2,5 Mg/Ml)
Busulfan 60 Mg
Busulfan 60 Mg (6 Mg/Ml) Vial
Carboplatino 450 Mg
Carboplatino 450 Mg (10 Mg/Ml) Vial
Carbo... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Parenteral Cytostatic Medications with Active Ingredients Cabazitaxel, Arsenic Trioxide, Paclitaxel, Paclitaxel-Albumin, Bendamustina, Bortzomib, Busulfan, Carboplatin, Cisp ... - Spain Tender
The MURCIAN HEALTH SERVICE - PURCHASING BOARD, a Government sector organization in Spain, has announced a new tender for Supply of Parenteral Cytostatic Medications with Active Ingredients Cabazitaxel, Arsenic Trioxide, Paclitaxel, Paclitaxel-Albumin, Bendamustina, Bortzomib, Busulfan, Carboplatin, Cisp .... This tender is published on SpainTenders under EST Ref No: 119636913 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-27.
The estimated tender value is EUR 158400, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
